|
⚲
|
| Keyboard |
| Levine James E
✚
|
|
|---|---|
| CIK # | 0001463151 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001463151] | |
| 4 | [0001463151] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kazia Therapeutics Ltd | |
| Levine James E | |
| Cardiff Oncology Inc | |
| K2 Therapeutics Inc | |
| Verenium Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cardiff Oncology Inc CRDF
Stock Options · derivative
|
2025-03-11 | Grant | 332,621 | $0.00 | |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2024-12-18 | Buy | 2,400 | $5.00 | 12,000 |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2024-12-17 | Buy | 2,752 | $5.42 | 14,916 |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2024-12-16 | Buy | 2,564 | $3.83 | 9,820 |
|
Cardiff Oncology Inc CRDF
Stock Options · derivative
|
2024-03-07 | Grant | 205,008 | $0.00 | |
|
Cardiff Oncology Inc CRDF
Stock Options · derivative
|
2023-03-15 | Grant | 197,472 | $0.00 | |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2022-09-16 | Buy | 30,000 | $1.56 | 46,800 |
|
Cardiff Oncology Inc CRDF
Stock Options · derivative
|
2022-03-09 | Grant | 170,016 | $0.00 | |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2021-09-10 | Buy | 5,000 | $6.32 | 31,600 |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2021-09-10 | Buy | 5,000 | $6.62 | 33,100 |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2021-09-10 | Buy | 5,000 | $6.75 | 33,750 |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2021-09-10 | Buy | 10,000 | $6.38 | 63,800 |
|
Cardiff Oncology Inc CRDF
Common Stock
|
2021-09-10 | Buy | 5,000 | $6.35 | 31,750 |
|
Cardiff Oncology Inc CRDF
Common Stock · derivative
|
2021-07-12 | Grant | 390,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2021-03-17 | Grant | 130,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2020-11-10 | Buy | 50,000 | $2.01 | 100,500 |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2020-03-19 | Grant | 25,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2020-03-19 | Option exercise | 110,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Subscription Rights (right to buy) · derivative
|
2020-01-28 | Option exercise | 6,891 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2020-01-28 | Option exercise | 6,891 | $2.51 | 17,296 |
| showing 20 of 38 most recent transactions | |||||